Erin E Mcgintee, M.D. is an allergy immunology in Southampton, NY with 24 years of experience. The provider is an allergist-immunologist is trained in evaluation, physical and laboratory diagnosis, and management of disorders involving the immune system. Selected examples of such conditions include asthma, anaphylaxis, rhinitis, eczema, and adverse reactions to drugs, foods, and insect stings as well as immune deficiency diseases (both acquired and congenital), defects in host defense, and problems related to autoimmune disease, organ transplantation, or malignancies of the immune system. Erin E Mcgintee, M.D. NPI is 1295750412. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
Education
Medical School: STATE UNIVERSITY OF NEW YORK AT STONY BROOK, SCHOOL OF MEDICINE
Graduation Year:2000
The provider's business location address is:
365 COUNTY ROAD 39A
BENTON PLAZA, UNIT #3
SOUTHAMPTON, NY
ZIP 11968
Phone: (631) 283-1142
The NPI 1295750412 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection of allergenic extracts into skin, accessed through the skin (HCPCS:95004)
- Injection of allergenic extracts into skin for immediate reaction analysis (HCPCS:95024)
- Injection of incremental dosages of allergen, 2 or more injections (HCPCS:95117)
- Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
- Measurement and graphic recording of total and timed exhaled air capacity (HCPCS:94010)
The enumeration date for this NPI number is 7/12/2006 and was last updated on 4/3/2019.